ncAA Incorporated Peptide Library Development
Creating diverse libraries of peptides containing ncAAs at defined positions for high-throughput screening to identify leads with novel binding or functional properties.
Genetic code expansion (GCE) technology represents a transformative approach in molecular biology, enabling the site-specific incorporation of non-canonical amino acids (ncAAs) into proteins and peptides. The ncAA-incorporated peptide engineering focuses on the rational design and production of peptides containing precisely positioned ncAAs to confer novel properties, such as enhanced stability, unique conjugation handles, or new biological activities. As a pioneering biotech leader and trusted partner in preclinical services, our company facilitates this area's progress by providing a proprietary GCEngine platform. This service supports the entire development lifecycle, from identifying novel orthogonal pairs to applying ncAA-incorporated peptides, offering researchers precise control over molecular structure and function.
ncAA incorporated peptide engineering represents a specialized application of GCE technology aimed at the creation of next-generation peptide-based molecules. This process involves the co-translational insertion of chemically diverse ncAAs at predetermined sites within a peptide sequence during biosynthesis. This precise modification allows for the introduction of functionalities not found in natural amino acids, such as bio-orthogonal chemical groups (e.g., azides, alkynes), post-translational modification mimics, fluorophores, or moieties that modulate pharmacokinetic properties. The result is a class of engineered peptides with tailor-made characteristics for applications in research and drug development.
Fig.1 Synthesis of ultrashort antimicrobial peptides with the non-canonical amino acid. (Peggion, C., et al., 2025).
Pharmaceutical Development
Generating peptide therapeutics with tailored properties such as enhanced metabolic stability, improved membrane permeability, and optimized target engagement.
Chemical Biology & Probe
Facilitating the site-specific attachment of fluorophores, affinity tags, or cross-linkers to create precision tools for studying protein interactions, cellular dynamics, and biological mechanisms.
Biomaterials & Synthetic Biology
Designing novel peptide-based biomaterials by incorporating ncAAs to program specific self-assembly behaviors, catalytic activities, or responsive functionalities.
Diagnostics & Imaging
Developing highly specific detection reagents and imaging probes through bio-orthogonal conjugation handles introduced via ncAAs, improving sensitivity and signal-to-noise ratios.
Vaccine Development
Creating precisely defined antigenic peptides bearing ncAA tags for controlled linkage to carriers or adjuvants, aiding in the development of reproducible and potent vaccine candidates.
Basic Research & Discovery
Expanding the chemical diversity of peptides to investigate protein function, stabilize bioactive conformations, and explore structure-activity relationships in fundamental biological processes.
Powered by our proprietary, high-throughput GCEngine platform, we offer a comprehensive suite of services for ncAA incorporated peptide engineering. Our integrated workflow spans from the initial identification and optimization of novel orthogonal aaRS/tRNA pairs specific to client-chosen ncAAs, through rigorous in vitro validation of ncAA incorporation efficiency and fidelity, to the in vivo application. Our team provides expert guidance and execution at every stage, from initial design and genetic construct optimization to peptide purification and functional characterization.
ncAA Incorporated Peptide Library Development
Creating diverse libraries of peptides containing ncAAs at defined positions for high-throughput screening to identify leads with novel binding or functional properties.
ncAA Incorporated Peptide Therapy Development
End-to-end support in engineering therapeutic peptide candidates, from early-stage design and stability enhancement to application for preclinical studies.
Immunomodulatory Peptide Therapy Development
Designing peptides incorporating ncAAs that can modulate immune checkpoint interactions, cytokine signaling, or other immune pathways with potential for improved specificity or half-life.
ncAA Incorporated Peptide Vaccine Development
Engineering antigenic peptide epitopes containing ncAA tags for controlled, homogeneous conjugation to carrier molecules, aiding in the development of defined and potentially more potent conjugate vaccine candidates.
Our ncAA incorporated peptide engineering services are tailored to address complex challenges across multiple therapeutic domains. By enabling precise chemical modifications, this technology facilitates the development of next-generation peptide candidates with properties optimized for specific disease mechanisms and delivery requirements.
Offering an end-to-end partnership, our unique value lies in the integration of a proprietary GCEngine platform with extensive preclinical peptide engineering experience. This can reduce timelines, increase success rates for challenging ncAA incorporations, and provide access to expertly designed, functionally validated peptides. We are committed to providing flexible, collaborative, and scientifically rigorous support to advance innovative research and therapeutic programs. For detailed project consultations and to explore how our ncAA incorporated peptide engineering services can meet your specific needs, please contact our scientific team.
All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.